Mucositis in Oncology

Marion Debus

Last update: 25.06.2019

Mucous membrane damage in the mouth area (mucositis) is an expression of a reduced ability of the mucous membranes to regenerate and indicates a weakened life organization (etheric body). It often occurs after local radiation therapy or intensive chemotherapy, and in late palliative stages. In this condition, salivary flow is reduced and painful aphthae (ulcers) and unpleasant coatings can occur, with the risk of oral thrush. The ability to eat is limited, or eating may not be possible at all. The therapeutic aim is to support the patient’s etheric upbuilding and regenerative forces in the mucous membrane area.

Reduced functional saliva production is also extremely common. When anticipating a nicely prepared meal, people experience the mental sensation of appetite, which has its origin in the soul body and which gives the impulse for salivary secretion – i.e., “their mouth waters”. Numerous drugs (such as opioid analgesics, neuroleptics, anticonvulsants, antihistamines, antidepressants and sleeping pills) cause dry mouth as a side effect. What these medications have in common is that they release the soul, which has been intervening too strongly in the physical and causing pain or itching. As a result, the released soul can no longer intervene sufficiently in the area of the glandular organization, so that salivary secretion is also impaired. The condition of dry mouth is further exacerbated by limited chewing, as well as a lack of fluid and food intake in advanced stages of a disease. Almost all patients suffer from this in the terminal stage, when their soul and spirit are already gradually separating from their body.  

Strong feelings, which throw people completely back on their soul experience and prevent a healthy connection with the body (such as fear, or not wanting something to be true, or severe depressive moods) can also lead to dry mouth.

The therapeutic approach

The therapeutic aim in the case of a persistent dry mouth with reduced saliva production is to promote everything that brings the ‘I’ and soul body into a healthy relationship with the outside world, through stimulating sensory perceptions in the broadest sense, because sensations give the impulse for glandular activity. The patient’s “appetite” should not only be stimulated in relation to food (e.g., with sour candies or ginger) but also in relation to various other sensory perceptions (e.g., via odors, color impressions in painting therapy, or deliberately formed speech in anthroposophic speech therapy). 

If anxiety or depression are simultaneously present, they should be treated with the appropriate medications, nursing care and therapies (see article on Fear: https://www.anthromedics.org/PRA-0563-EN). The sole suppression of anxiety with anxiolytics should be avoided, if possible, as this can increase dry mouth.

 

Research news

Phase IV trial: Kalium phosphoricum comp. versus placebo in irritability and nervousness 
In a new clinical study, Kalium phosphoricum comp. (KPC) versus placebo was tested in 77 patients per group. In a post-hoc analysis of intra-individual differences after 6 weeks treatment, a significant advantage of KPC vs. placebo was shown for characteristic symptoms of nervous exhaustion and nervousness (p = 0.020, p = 0.045 respectively). In both groups six adverse events (AE) were assessed as causally related to treatment (severity mild or moderate). No AE resulted in discontinuation in treatment. KPC could therefore be a beneficial treatment option for symptomatic relief of neurasthenia. The study has been published open access in Current Medical Research and Opinion
https://doi.org/10.1080/03007995.2023.2291169.


Further information on Anthroposophic Medicine